INS and diabetes mellitus: In human clinical trials, injection of bone marrow-derived MSCs to patients with diabetes, specifically those with type 2 diabetes mellitus, improved the function of β cells, reduced the incidence of diabetic complications, and even led to insulin independence in some patients [7].